Chicken Lymphoma
|
disease |
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Elevated urinary catecholamines
|
phenotype |
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Neural crest tumor
|
disease |
Neoplasms; Endocrine System Diseases
|
Disease or Syndrome
|
18
|
1
|
0.300 |
None |
1.000 |
2 |
|
2006 |
2008 |
Fibromatosis
|
disease |
Neoplasms
|
Neoplastic Process
|
22
|
5
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Leukemia secondary
|
disease |
|
Neoplastic Process
|
24
|
4
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Myomatous neoplasm
|
disease |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Infant Leukemia
|
disease |
|
Neoplastic Process
|
27
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Treatment related leukaemia
|
disease |
Neoplasms
|
Neoplastic Process
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Nevus comedonicus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
31
|
6
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Thymus Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
31
|
1
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Carcinoma of anal margin
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Serous Tubal Intraepithelial Carcinoma
|
disease |
|
Neoplastic Process
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Chronic glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
41
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Breast cancer recurrent
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
41
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Anal carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
42
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Metastatic human epidermal growth factor 2 positive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
42
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Neoplasms, Neuroepithelial
|
group |
Neoplasms
|
Neoplastic Process
|
46
|
5
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Plexiform Neurofibroma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
46
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pseudomyxoma Peritonei
|
disease |
Neoplasms
|
Neoplastic Process
|
50
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
gallbladder neoplasm
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
51
|
6
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Metastatic Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
61
|
1
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Craniopharyngioma
|
disease |
Neoplasms
|
Neoplastic Process
|
64
|
7
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Treatment related acute myeloid leukaemia
|
disease |
|
Neoplastic Process
|
65
|
4
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2014 |
Tuberculosis, Multidrug-Resistant
|
disease |
Infections
|
Disease or Syndrome
|
67
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hip circumference
|
phenotype |
|
Clinical Attribute
|
68
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |